55 related articles for article (PubMed ID: 8859287)
41. Therapeutic alternatives in cutaneous T-cell lymphoma.
Holloway KB; Flowers FP; Ramos-Caro FA
J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
[TBL] [Abstract][Full Text] [Related]
42. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
43. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
45. Extracorporeal Photopheresis in Dermatological Diseases.
Terhaar H; Saleem M; Yusuf N
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474257
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous T-cell lymphomas.
Kaplan EH; Leslie WT
Curr Opin Oncol; 1993 Sep; 5(5):812-8. PubMed ID: 7692980
[TBL] [Abstract][Full Text] [Related]
47. Photopheresis: clinical applications and mechanism of action.
Rook AH; Suchin KR; Kao DM; Yoo EK; Macey WH; DeNardo BJ; Bromely PG; Geng Y; Junkins-Hopkins JM; Lessin SR
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):85-90. PubMed ID: 10537015
[TBL] [Abstract][Full Text] [Related]
48. Photopheresis in the 1990s.
Christensen I; Heald P
J Clin Apher; 1991; 6(4):216-20. PubMed ID: 1840064
[No Abstract] [Full Text] [Related]
49. Photopheresis: present and future aspects.
Edelson RL
J Photochem Photobiol B; 1991 Jul; 10(1-2):165-71. PubMed ID: 1955944
[No Abstract] [Full Text] [Related]
50. Extracorporeal photopheresis.
Gross M; Boh EE; Millikan LE
Int J Dermatol; 1994 Jun; 33(6):407-11. PubMed ID: 8056471
[No Abstract] [Full Text] [Related]
51. Photopheresis therapy for cutaneous T-cell lymphoma.
Duvic M; Hester JP; Lemak NA
J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
[TBL] [Abstract][Full Text] [Related]
53. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
Zic JA
Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
[TBL] [Abstract][Full Text] [Related]
54. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
55. Photopheresis for the treatment of cutaneous T-cell lymphoma.
Lim HW; Edelson RL
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
